Association of insulin-like growth factor-binding protein-3 with radiotherapy response and prognosis of esophageal squamous cell carcinoma

被引:4
|
作者
LiLing Luo [1 ,2 ,3 ]
Lei Zhao [1 ,2 ,3 ]
Mian Xi [1 ,2 ,3 ]
LiRu He [1 ,2 ,3 ]
JingXian Shen [1 ,4 ,3 ]
QiaoQiao Li [1 ,2 ,3 ]
ShiLiang Liu [1 ,2 ,3 ]
Peng Zhang [1 ,2 ,3 ]
Dan Xie [1 ,3 ]
MengZhong Liu [1 ,2 ,3 ]
机构
[1] Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine
[2] Department of Radiation Oncology, Sun Yat-sen University Cancer Center
[3] Collaborative Innovation Center for Cancer Medicine
[4] Medical Imaging and Interventional Center, Sun Yat?sen University Cancer
关键词
D O I
暂无
中图分类号
R735.1 [食管肿瘤];
学科分类号
摘要
Background: Insulin?like growth factor?binding protein?3(IGFBP?3) is suggested to predict the radiosensitivity and/or prognosis of patients with esophageal squamous cell carcinoma(ESCC). The present study was designed to investi?gate the clinical and prognostic efects of IGFBP?3 on ESCC.Methods: IGFBP?3 was detected by immunohistochemistry in parain?embedded tissues from 70 ESCC patients treated with radiotherapy alone and further examined by western blotting analysis in 10 pairs of fresh ESCC tissues and adjacent non?malignant esophageal specimens. Receiver operating characteristic(ROC) analysis was used to determine cut?of scores for tumor positivity and to evaluate patient survival status. The χ2 test was performed to analyze the association of IGFBP?3 expression with clinical characteristics and radiotherapy response. Associations between prognostic outcomes and IGFBP?3 expression were investigated using Kaplan–Meier analysis and the Cox proportional hazards model.Results: The threshold for IGFBP?3 positivity was set to greater than 65% [area under the ROC curve(AUC)(45.7%) were deined as having high IGFBP?3 expression= 0.690, P < 0.019]. Of the 70 ESCC patient tissues tested, 32. The levels of IGFBP?3 protein expression were decreased in 70.0%(7 of 10) of ESCC tissues compared with adjacent non?malignant esophageal tissue. In addition, IGFBP?3 expression was associated with pathologic classiication(P < 0.05 for T, N, and M categories and clinical stage). Patients with elevated protein level of IGFBP?3 in the tumor had an improved radiotherapy response and prolonged overall survival(P < 0.001).Conclusions: High level of IGFBP?3 expression in ESCC associates with early clinical stages and are predictive for favorable survival of the patients treated with radiotherapy.
引用
收藏
页码:514 / 521
页数:8
相关论文
共 50 条
  • [21] EXPRESSION OF HUMAN INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-3 IN TRANSGENIC MICE
    MURPHY, LJ
    MOLNAR, P
    LU, X
    HUANG, H
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 1995, 15 (03) : 293 - 303
  • [22] Proteolysis of insulin-like growth factor-binding protein-3 in the male reproductive tract
    Plymate, SR
    Rosen, CJ
    Paulsen, CA
    Ware, JL
    Chen, JZ
    Vessella, RE
    Birnbaum, RS
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (02): : 618 - 624
  • [23] Insulin-like Growth Factor-binding Protein-3 in Osteosarcomas and Normal Bone Tissues
    Ressler, Sigrun
    Radhi, Jasim
    Aigner, Thomas
    Loo, Christine
    Zwerschke, Werner
    Sergi, Consolato
    ANTICANCER RESEARCH, 2009, 29 (07) : 2579 - 2587
  • [24] Isolation and characterization of proteolytic fragments of insulin-like growth factor-binding protein-3
    Lalou, C
    Lassarre, C
    Binoux, M
    HORMONE RESEARCH, 1996, 45 (3-5) : 156 - 159
  • [25] INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-3 IS FUNCTIONALLY NORMAL IN PREGNANCY SERUM
    SUIKKARI, AM
    BAXTER, RC
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (01): : 177 - 183
  • [26] A new method for the purification of bioactive insulin-like growth factor-binding protein-3
    Pircher, Haymo
    Matscheski, Andrea
    Laich, Andreas
    Hermann, Martin
    Moser, Barbara
    Viertler, Hans-Peter
    Micutkova, Lucia
    Lindner, Herbert
    Sarg, Bettina
    Zwerschke, Werner
    Jansen-Duerr, Pidder
    PROTEIN EXPRESSION AND PURIFICATION, 2010, 71 (02) : 160 - 167
  • [27] Predictors of Circulating Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor-Binding Protein-3 in Critical Illness
    Ahasic, Amy M.
    Tejera, Paula
    Wei, Yongyue
    Su, Li
    Mantzoros, Christos S.
    Bajwa, Ednan K.
    Thompson, B. Taylor
    Christiani, David C.
    CRITICAL CARE MEDICINE, 2015, 43 (12) : 2651 - 2659
  • [28] Biosensor measurement of the binding of insulin-like growth factors I and II and their analogues to the insulin-like growth factor-binding protein-3
    Heding, A
    Gill, R
    Ogawa, Y
    DeMeyts, P
    Shymko, RM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (24) : 13948 - 13952
  • [29] Insulin-like growth factor-binding protein-3 activates a phosphotyrosine phosphatase - Effects on the insulin-like growth factor signaling pathway
    Ricort, JM
    Binoux, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (22) : 19448 - 19454
  • [30] Reproducibility of serum leptin, insulin-like growth factor-I, and insulin-like growth factor-binding protein-3 measurements
    Chia, Victoria M.
    Newcomb, Polly A.
    White, Emily
    Zheng, Yingye
    Potter, John D.
    Lampe, Johanna W.
    HORMONE RESEARCH, 2008, 69 (05) : 295 - 300